Total
0
Shares
BioHarvest Sciences Inc. (CSE:BHSC) delivers record first-quarter sales of VINIA in Israel
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Sales of VINIA® in Q1/2021 reached an all-time high of US$ 377,756, representing a 668 per cent increase over Q1/2020
  • The average dollar purchase amount for first-time customers is $ 169, far exceeding the acquisition costs
  • BioHarvest will use the knowledge gained from the Israeli launch as it prepares to launch VINIA® in the U.S.
  • BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology
  • BioHarvest Sciences Inc. (BHSC) is down 2.13 per cent, trading at C$0.46 per share at 11 am ET

BioHarvest Sciences Inc (BHSC) announced that sales of VINIA® in Q1/2021 reached an all-time high of US$ 377,756.

This represents a 668 per cent increase over Q1/2020.

The total number of VINIA® purchase orders in Q1/2021 also reached a new high of 2,190, an increase of 45% versus Q4/2020. 

The average dollar purchase amount for first-time customers is $ 169, far exceeding the acquisition cost for these customers.

The consistent traction achieved by VINIA® highlights the recognition by the Israeli consumer of the quality and efficacy of VINIA®. 

The knowledge and experience gained from the launch of VINIA® in the Israeli market will benefit the company as it prepares to launch VINIA® in the US market.

The BioHarvest marketing team is leveraging this experience to optimize the consumer messaging and the customer acquisition process to achieve a successful launch in the US market.  

“I am proud of the company’s achievements in the last quarter”, said Ilan Sobel, CEO of BioHarvest.

“I made a commitment to all BioHarvest stakeholders to build a professional team and bring Best in Class talents to support all the facets of a fully operational company. The sales results of Q1 are a testimony to their talent, which has allowed the company to grow from an R&D organization into one that has all the elements needed to bring highly differentiated wellness products to the end consumer.

I look forward to the company continuing its momentum in Israel during Q2 and beyond and to disrupting the US market shortly, with the launch of VINIA® in that region.”  

Canadian-based BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology.

The company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA® and other Super Fruit Nutraceutical products. By adapting this technology to the cannabis plant, and building adequate production capacity, BioHarvest Sciences Inc.’s objective is to become a leading supplier of cannabis for both medicinal and legal recreational purposes.

BioHarvest Sciences Inc. (BHSC) is down 2.13 per cent, trading at C$0.46 per share at 11 am ET.

More From The Market Herald
BC Craft Supply Co. - CFO Anthony Laud - The Market Herald Canada

" BC Craft Supply (CSE:CRFT) appoints Anthony Laud as Chief Financial Officer

BC Craft Supply Co. (CRFT) has appointed Anthony Laud as its new Chief Financial Officer.
Dash Capital (TSXV:DCX.P) signs LOI for qualifying transaction

" TransCanna (CSE:TCAN) launches new revenue stream

TransCanna Holdings (TCAN) has onboarded its first client for third-party cold storage, Kase Manufacturing.
Simply Better Brands (TSXV:SBBC) acquires interest in the Crisp Group

" Simply Better Brands (TSXV:SBBC) acquires interest in the Crisp Group

Simply Better Brands (SBBC) has completed its acquisition of a 60 per cent interest in Crisp Management Group Inc.
Aleafia Health (TSX:AH) launches cannabis soft chews

" Pure Extracts (CSE:PULL) ships initial order of edible gummies to Alberta

Pure Extracts Technologies (PULL) has shipped its initial order of edible gummies to Alberta Gaming, Liquor & Cannabis (AGLC).